Navigation Links
RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
Date:8/25/2008

Company Receives Approval from Chinese Health Authorities to Launch Final

Clinical Trial for Asacard(R)

NEW HAVEN, Conn., Aug. 25 /PRNewswire/ -- RHEI Pharmaceuticals, Inc. today announced the appointment of Dr. Geert Cauwenbergh as Chief Executive Officer. Dr. Cauwenbergh succeeds Joos Horsten, who recently passed away. Dr Cauwenbergh has been assisting RHEI Pharmaceuticals since August 1, 2008 in providing the necessary leadership to continue the Company's development.

"I am honored to follow in the footsteps of Joos Horsten, a serial entrepreneur who was a key figure in the development of the Western pharmaceutical industry in China," noted Dr. Cauwenbergh. "As a result of Joos' leadership and foresight, RHEI Pharmaceuticals is uniquely positioned to accelerate the availability of already approved western medicines in the Chinese market and I am fortunate to be working with the world-class team that Joos had assembled in order to pursue its growth strategy."

The Company also announced today that it has received approval from the Chinese Health Authorities to launch its final clinical study for Asacard(R), a controlled release formulation of aspirin. With this approval in place, RHEI Pharmaceuticals has a low-risk pipeline of novel western medicines lined up for the Chinese market, with multiple product launches expected over the next few years.

Commenting on this news, Dr. Cauwenbergh stated, "With one potential launch this year, followed by three in 2009 (including Asacard(R)) and an additional product launch planned each year thereafter until 2012, RHEI Pharmaceuticals is expected to achieve very rapid growth. It is our goal to become the partner of choice for western companies that want to tap into the fast growing Chinese Health Care market, as well as for those Chinese companies that are interested in distributing western drugs, domestically."

Prior to joining RHEI Pharmaceuticals, in February 2
'/>"/>

SOURCE RHEI Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
2. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
3. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
4. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
5. MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
6. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
7. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
8. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
9. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
10. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
11. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2
...search,organization, is pleased to announce that l...r for the Czech Republic, received GCPj,s "Best,Cl...remony was held in,London,s historic Gibson Hall. ...panel of judges who,reviewed his achievements in t...nical trials. The judging panel was composed of a ...
...a,leading, global full-service clinical research o...ident and Chief Financial Officer Karl,"Buzz" Bren...h Annual,Healthcare Conference at the Grand Hyatt ...ity, Sept. 10-11, 2007. Kendle,s presentation is,s...n Time. (Logo: http://www.newscom.com/cgi-bin/pr...
...d of,Pharmacy has approved a 14-module, eight-hour...ewood Pharmacy. The program was developed by the,c...Department. Upon,completion of the program, each t...rate a high level of competence in all state rules... Portability and Accountability Act,(HIPAA) regula...
Other Biology Technology:Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year 2Kendle to Present at Bear Stearns 20th Annual Healthcare Conference 2NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program 2NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program 3
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
Breaking Biology News(10 mins):How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 33SBio Inc Announces Results of Annual General Meeting 5580 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 2SURF CRUISE CUP 2009 59783 1SURF CRUISE CUP 2009 59783 2
...heres no doubt about it ... the platypus is one od...adaptations like webbed feet to fit its aquatic li...the platypus represents for many a patchwork of ev...g with an international consortium of scientists l... Louis, Mo., has taken this theory to an entirely ...
...onal commerce of ornamental stones has grown all o...ed solid support to the aesthetics of natural ston...on. , Marble is, undoubtedly, the ornamental ston...vilizations have architectural or sculptural works...ir historic heritage. Despite this, nowadays we ha...
...ghts: , Mechanism of action of compound found to... The findings may lead researchers to develop pot...e, amyotrophic lateral sclerosis, Huntingtons dise...nant gliomas , RICHMOND, Va. (May 9, 2008) Virg...overed how an antibiotic works to modulate the act...
Other Biology News:First analysis of platypus genome may impact disease prevention 2Development of new techniques to understand marble quality and durability 2Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain 2Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain 3
...ore tubes to 1 outflow Single-cell and patch deli...everal millisecond) solution change Very small de...on , Solid construction 360, 250 and 100 micro...ny micromanipulator Available in 4, 8, and 16 cha...
steadylite plus Reporter Gene Assay System, 100 mL from PerkinElmer
pTRI-GAPDH-Human (316 bp protected fragment) from Ambion
...nsect Medium is formuatled for the growth of insec... Insect Mediu, Unsupplemented is ideal for transfe...rosylate, and yeastolate, which can interfere with... is formulated for general growth and maintenance ...
Biology Products: